Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
O75616
UPID:
ERAL1_HUMAN
Alternative names:
Conserved ERA-like GTPase; ERA-W; ERA-like protein 1
Alternative UPACC:
O75616; B3KN21; C9JEC6; O75617; Q8WUY4; Q96LE2; Q96TC0
Background:
The GTPase Era, mitochondrial, also known as Conserved ERA-like GTPase, ERA-W, and ERA-like protein 1, plays a crucial role in mitochondrial ribosomal small subunit assembly. It specifically binds the 12S mitochondrial rRNA to a 33 nucleotide section, delineating the 3' terminal stem-loop region, acting as a chaperone for the 12S mt-rRNA during ribosomal assembly.
Therapeutic significance:
Linked to Perrault syndrome 6, a disorder characterized by sensorineural deafness and, in females, ovarian dysgenesis, the study of GTPase Era, mitochondrial, offers a pathway to understanding and potentially treating this autosomal recessive disease.